Stay updated on AEB1102 Dose Escalation in Advanced Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the AEB1102 Dose Escalation in Advanced Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the AEB1102 Dose Escalation in Advanced Solid Tumors Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Glossary toggle options (Show glossary / Hide glossary) were added, and the footer now shows Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0. Previously, the footer displayed Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4.
    Difference
    0.3%
    Check dated 2026-01-22T17:34:41.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    Revision label updated from v3.3.3 to v3.3.4. This is a minor update; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-15T10:42:48.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    37 days ago
    Change Detected
    Summary
    New locations have been added under Contacts and Locations, listing Arizona, California, Colorado, Florida, Massachusetts, Missouri, New York, Oregon, Pennsylvania, and Texas. The page shows revision v3.3.3 and removes the prior per-state location subsections and the HHS Vulnerability Disclosure link.
    Difference
    1%
    Check dated 2025-12-17T18:53:56.000Z thumbnail image
  5. Check
    58 days ago
    Change Detected
    Summary
    Revision label updated from v3.2.0 to v3.3.2. This appears to be a maintenance update with no changes to trial data or eligibility.
    Difference
    0.1%
    Check dated 2025-11-26T13:51:44.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    Removed the government funding lapse notice banner from the page footer; the trial details, eligibility criteria, and outcomes remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-19T08:33:27.000Z thumbnail image
  7. Check
    87 days ago
    Change Detected
    Summary
    No significant changes detected in core study details, eligibility criteria, or locations; minor UI tweaks observed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-10-28T05:12:06.000Z thumbnail image

Stay in the know with updates to AEB1102 Dose Escalation in Advanced Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the AEB1102 Dose Escalation in Advanced Solid Tumors Clinical Trial page.